$EMR earnings report

Emerson Reports Fourth Quarter and Full Year 2026 Results; Provides Initial 2027 Outlook. AlphAI read Emerson Electric's Q4 2026 and fiscal year 2026 filing as strong. 3 quarters are on record below.

Q4 2026 and fiscal year 2026

AlphAI · Earnings readEMR · Q4 2026 and fiscal year 2026 · ended September 30, 2026

Emerson Reports Fourth Quarter and Full Year 2026 Results; Provides Initial 2027 Outlook

✓Strong quarter

Fourth-quarter and full-year sales, earnings, margins, cash flow and adjusted EPS increased versus the corresponding 2025 periods, while the company initiated 2027 growth, earnings and cash-flow guidance and outlined approximately $3.8B of planned capital returns.

Revenue
$5.20B
7% y/y
Q4 2026 Control Systems & Software
$1.25B
14% y/y
EPS · non-GAAP
$1.86
15% y/y
2027 Q1 and 2027 outlook
2027 Q1 net sales growth ~5%; 2027 net sales growth ~5%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q4 2026 net salesGAAP$5.20B–7%
FY 2026 net salesGAAP$18.98B–5%
Q4 2026 underlying ordersother14%–14%
FY 2026 underlying ordersother9%–9%
Q4 2026 underlying salesnon-GAAP7%–7%
FY 2026 underlying salesnon-GAAP4%–4%
Q4 2026 pretax earningsGAAP$997M––
Q4 2026 pretax earnings marginGAAP19.2%–360 bps
FY 2026 pretax earningsGAAP$3.49B––
FY 2026 pretax earnings marginGAAP18.4%–230 bps
Q4 2026 adjusted EBITAnon-GAAP$1.41B––
Q4 2026 adjusted EBITA marginnon-GAAP27.1%––
FY 2026 adjusted EBITAnon-GAAP$5.05B––
FY 2026 adjusted EBITA marginnon-GAAP26.6%––
Q4 2026 adjusted segment EBITAnon-GAAP$1.51B––
Q4 2026 adjusted segment EBITA marginnon-GAAP29.1%–160 bps
FY 2026 adjusted segment EBITAnon-GAAP$5.36B––
FY 2026 adjusted segment EBITA marginnon-GAAP28.2%–60 bps
Q4 2026 earnings from continuing operationsGAAP$744M––
FY 2026 earnings from continuing operationsGAAP$2.69B––
Q4 2026 net earningsGAAP$744M––
FY 2026 net earningsGAAP$2.69B––
Q4 2026 net earnings common stockholdersGAAP$744M––
FY 2026 net earnings common stockholdersGAAP$2.69B––
Q4 2026 GAAP earnings from continuing operations per shareGAAP$1.33–24%
FY 2026 GAAP earnings from continuing operations per shareGAAP$4.79–20%
Q4 2026 adjusted earnings from continuing operations per sharenon-GAAP$1.86–15%
FY 2026 adjusted earnings from continuing operations per sharenon-GAAP$6.59–10%
Q4 2026 operating cash flowGAAP$1.07B–6%
FY 2026 cash from continuing operationsGAAP$3.98B–8%
Q4 2026 free cash flownon-GAAP$916M–9%
FY 2026 free cash flownon-GAAP$3.54B–9%

Segments

SegmentRevenueq/qy/y
Q4 2026 Control Systems & SoftwareReported sales growth was 14%; underlying sales growth was 14%.$1.25B–14%
Q4 2026 Test & MeasurementReported sales growth was 14%; underlying sales growth was 15%.$465M–14%
Q4 2026 Software & SystemsReported sales growth was 14%; underlying sales growth was 14%.$1.71B–14%
Q4 2026 SensorsReported sales growth was 4%; underlying sales growth was 3%.$1.19B–4%
Q4 2026 Final ControlReported sales growth was 5%; underlying sales growth was 5%.$1.73B–5%
Q4 2026 Intelligent DevicesReported sales growth was 5%; underlying sales growth was 4%.$2.92B–5%
Q4 2026 Safety & ProductivityReported sales growth was 2%; underlying sales growth was 2%.$573M–2%
FY 2026 Control Systems & SoftwareReported sales growth was 6%; underlying sales growth was 5%.$4.58B–6%
FY 2026 Test & MeasurementReported sales growth was 17%; underlying sales growth was 15%.$1.73B–17%
FY 2026 Software & SystemsReported sales growth was 8%; underlying sales growth was 7%.$6.31B–8%
FY 2026 SensorsReported sales growth was 4%; underlying sales growth was 3%.$4.30B–4%
FY 2026 Final ControlReported sales growth was 4%; underlying sales growth was 2%.$6.19B–4%
FY 2026 Intelligent DevicesReported sales growth was 4%; underlying sales growth was 3%.$10.50B–4%
FY 2026 Safety & ProductivityReported sales growth was 3%; underlying sales growth was 2%.$2.17B–3%

Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.

2027 Q1 and 2027 outlook

  • Revenue2027 Q1 net sales growth ~5%; 2027 net sales growth ~5%
  • Note2027 Q1 underlying sales growth ~5%; 2027 underlying sales growth ~5%
  • Note2027 Q1 earnings per share $1.19 - $1.23; 2027 earnings per share ~$5.70
  • Note2027 Q1 amortization of intangibles ~$0.35; 2027 amortization of intangibles ~$1.41
  • Note2027 Q1 restructuring and related costs ~$0.04; 2027 restructuring and related costs ~$0.14
  • Note2027 Q1 adjusted earnings per share $1.58 - $1.62; 2027 adjusted earnings per share ~$7.25
  • Note2027 operating cash flow $4.3B - $4.4B
  • Note2027 free cash flow $3.8B - $3.9B
  • Note2027 Q1 share repurchase ~$1.5B; 2027 share repurchase ~$2.5B

Capital returns

  • Emerson declared a 7% quarterly cash dividend increase to $0.595 per share of common stock payable December 10, 2026 to stockholders of record November 13, 2026.
  • FY 2026 dividends paid were $(1,244).
  • FY 2026 purchases of common stock were $(1,000).
  • The 2027 guidance framework assumes returning ~$3.8B through ~$2.5B of share repurchases and ~$1.3B of dividends.
  • 2027 Q1 share repurchase guidance is ~$1.5B; 2027 share repurchase guidance is ~$2.5B.

What drove it

  • Management said underlying orders were up 14%, supported by exceptional long-cycle project activity in growth verticals.
  • Management said demand was broad-based, with substantial growth across all business groups and regions.
  • Q4 sales growth by geography was 9% in the Americas, 1% in Europe and 7% in Asia, Middle East & Africa.
  • FY 2026 sales growth by geography was 7% in the Americas, (1)% in Europe and 3% in Asia, Middle East & Africa.
  • Q4 Software & Systems reported sales increased 14%, including 14% in Control Systems & Software and 14% in Test & Measurement.
  • FY 2026 Test & Measurement reported sales increased 17%, the fastest reported growth among the listed businesses.

Concerns

  • FY 2026 Europe sales growth was (1)%.
  • FY 2026 interest expense, net was $334, versus $237.
  • FY 2026 restructuring and related costs were $227, versus $162.
  • FY 2026 changes in operating working capital were $(338), versus $(9).
  • 2027 guidance figures are approximate.

What to watch

  • Delivery against 2027 net sales growth guidance of ~5% and underlying sales growth guidance of ~5%.
  • Delivery against 2027 adjusted earnings per share guidance of ~$7.25 and earnings per share guidance of ~$5.70.
  • Conversion to 2027 operating cash flow of $4.3B - $4.4B and free cash flow of $3.8B - $3.9B.
  • Execution of planned returns of ~$3.8B, including ~$2.5B of share repurchases and ~$1.3B of dividends.
  • Whether robust backlog and favorable demand trends in growth verticals continue, as cited by management.

Balance sheet and cash flow

  • Cash and equivalents were $1,806 at September 30, 2026, versus $1,544 at September 30, 2025.
  • Short-term borrowings and current maturities of long-term debt were $4,667, versus $4,797.
  • Long-term debt was $7,508, versus $8,319.
  • FY 2026 cash provided by operating activities was $3,978, versus $3,098.
  • FY 2026 capital expenditures were $(443), versus $(431).
  • FY 2026 cash used in investing activities was $(455), versus $(593).
  • FY 2026 cash used in financing activities was $(3,222), versus $(4,510).
  • FY 2026 ending cash and equivalents were $1,806, versus $1,544.

Analysis

Emerson closed fiscal 2026 with Q4 net sales of $5,201, up 7% from $4,855, and underlying sales growth of 7%. Underlying orders increased 14%. Management attributed order performance to exceptional long-cycle project activity in growth verticals and described demand as broad-based across business groups and regions. Software & Systems posted 14% reported sales growth in the quarter, while Intelligent Devices grew 5% and Safety & Productivity grew 2%.

Profitability improved materially in Q4. GAAP pretax earnings were $997 with a 19.2% margin, versus $760 and 15.6%. Adjusted EBITA was $1,408 with a 27.1% margin, versus $1,269 and 26.1%, while adjusted segment EBITA rose to $1,511 and its margin expanded to 29.1% from 27.5%. GAAP earnings from continuing operations per share increased to $1.33 from $1.07, and adjusted earnings from continuing operations per share increased to $1.86 from $1.62.

For the full year, net sales reached $18,982, up 5%, with 4% underlying sales growth. FY 2026 pretax earnings increased to $3,489 from $2,905 and the pretax margin increased to 18.4% from 16.1%. Adjusted segment EBITA increased to $5,360 from $4,975, though its margin improvement was 60 bps to 28.2%. Test & Measurement was the fastest-growing listed business for the year, with 17% reported sales growth, while Europe sales growth was (1)%.

Cash generation also increased. Cash from continuing operations was $3,978, versus $3,676, and free cash flow was $3,535, versus $3,245. Emerson ended the year with $1,806 of cash and equivalents, $4,667 of short-term borrowings and current maturities of long-term debt, and $7,508 of long-term debt. The company paid $(1,244) in dividends and purchased $(1,000) of common stock during FY 2026.

The initial 2027 framework calls for ~5% net sales growth and ~5% underlying sales growth, ~$5.70 of earnings per share, ~$7.25 of adjusted earnings per share, $4.3B - $4.4B of operating cash flow and $3.8B - $3.9B of free cash flow. The framework assumes returning ~$3.8B through ~$2.5B of share repurchases and ~$1.3B of dividends. First-quarter guidance includes $1.19 - $1.23 of earnings per share, $1.58 - $1.62 of adjusted earnings per share and ~$1.5B of share repurchases.

Management, verbatim

Emerson capped a strong 2026 with fourth quarter sales and profitability exceeding expectations.

Lal Karsanbhai, President and Chief Executive Officer

Underlying orders were up 14%, supported by exceptional long-cycle project activity in our growth verticals. Demand was broad-based, with substantial growth across all business groups and regions.

Lal Karsanbhai, President and Chief Executive Officer

We have confidence in our 2027 plans given our robust backlog and favorable demand trends in our growth verticals.

Lal Karsanbhai, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Gross margin was not reported.
  • Operating income was not reported as a consolidated line item.
  • Prior-quarter comparisons were not reported for the listed key metrics.
  • A prior outlook section was not provided, so comparison of actual results with prior guidance is unavailable.
  • 2027 gross margin, operating-expense and tax-rate guidance were not reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Fiscal Year 2026 Third quarter

AlphAI · Earnings readEMR · Fiscal Year 2026 Third quarter · ended June 30

Emerson recast fiscal 2026 third-quarter and nine-month results to reflect adoption of mark-to-market accounting for defined benefit pension and other postretirement benefit plans.

✓Solid quarter

Third-quarter net sales, pretax earnings, net earnings common stockholders, diluted earnings per common share, adjusted EBITA and adjusted earnings per share were all higher than the corresponding fiscal 2025 third-quarter recast figures. The filing is a recast of prior reported results and contains no current-period operating commentary or forward outlook.

Revenue
$4.87B
EPS · non-GAAP
$ 1.71

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Third-quarter net salesGAAP$4.87B––
Third-quarter cost of salesGAAP2,218––
Third-quarter selling, general and administrative expensesGAAP1,343––
Third-quarter other deductions, netGAAP309––
Third-quarter interest expense, netGAAP85––
Third-quarter earnings before income taxesGAAP918––
Third-quarter income taxesGAAP198––
Third-quarter net earningsGAAP720––
Third-quarter net earnings common stockholdersGAAP$720M––
Third-quarter diluted earnings per common shareGAAP$ 1.28––
Third-quarter adjusted EBITAnon-GAAP$1.30B––
Third-quarter adjusted EBITA percent of salesnon-GAAP26.8 %––
Third-quarter adjusted earnings per sharenon-GAAP$ 1.71––
Nine months ended June 30 net salesGAAP$13.78B––
Nine months ended June 30 cost of salesGAAP6,393––
Nine months ended June 30 selling, general and administrative expensesGAAP3,902––
Nine months ended June 30 other deductions, netGAAP736––
Nine months ended June 30 interest expense, netGAAP258––
Nine months ended June 30 earnings before income taxesGAAP2,492––
Nine months ended June 30 income taxesGAAP544––
Nine months ended June 30 net earningsGAAP1,948––
Nine months ended June 30 net earnings common stockholdersGAAP$1.95B––
Nine months ended June 30 diluted earnings per common shareGAAP$ 3.46––
Nine months ended June 30 adjusted EBITAnon-GAAP$3.65B––
Nine months ended June 30 adjusted EBITA percent of salesnon-GAAP26.5 %––
Nine months ended June 30 adjusted earnings per sharenon-GAAP$ 4.72––

Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.

What drove it

  • The fiscal 2026 third-quarter recast reflects a $ 2 impact of mark-to-market change in pretax earnings.
  • Third-quarter adjusted EBITA reconciliation includes amortization of intangibles of 253, restructuring and related costs of 99, acquisition/divestiture fees and related costs of 32, and IEEPA tariff refunds of (82).
  • Third-quarter adjusted earnings per share reconciliation includes amortization of intangibles of 0.35, restructuring and related costs of 0.13, acquisition/divestiture fees and related costs of 0.05, discrete taxes of 0.01, and IEEPA tariff refunds of (0.11).

Concerns

  • The filing provides no segment revenue, orders, backlog, volume, pricing, geographic or end-market data.
  • The release contains no forward guidance, cash flow, balance-sheet, dividend, repurchase or debt information.
  • Fiscal 2026 results were recast following the adoption of mark-to-market accounting for defined benefit pension and other postretirement benefit plans.

What to watch

  • Whether future filings provide operating commentary and forward guidance following the recast.
  • The continuing effect of mark-to-market accounting on reported earnings.
  • The effect of IEEPA tariff refunds, which were (82) in the third-quarter adjusted EBITA reconciliation and (0.11) in the adjusted earnings per share reconciliation.

Analysis

This filing recasts Emerson's fiscal 2026 quarterly and nine-month results to reflect the adoption of mark-to-market accounting for defined benefit pension and other postretirement benefit plans. It does not provide a conventional earnings narrative, segment disclosure, management commentary or outlook. The reported third-quarter figures therefore establish revised historical comparatives rather than a new operational update.

Third-quarter net sales were $ 4,873, compared with $ 4,553 in fiscal 2025's third quarter and $ 4,562 in fiscal 2026's second quarter. Third-quarter earnings before income taxes were 918, compared with 737 a year earlier and 795 in the preceding quarter. Net earnings common stockholders were $ 720, versus $ 588 in the prior-year quarter and $ 620 in the second quarter. Diluted earnings per common share were $ 1.28, compared with $ 1.04 and $ 1.10, respectively.

The non-GAAP reconciliation reports third-quarter adjusted EBITA of $ 1,305 and adjusted EBITA percent of sales of 26.8 %, compared with $ 1,186 and 26.1 % in the fiscal 2025 third quarter, and $ 1,196 and 26.2 % in the fiscal 2026 second quarter. Adjusted earnings per share were $ 1.71, compared with $ 1.52 in the prior-year quarter and $ 1.55 in the preceding quarter. The quarter's adjustments include 253 of amortization of intangibles, 99 of restructuring and related costs, 32 of acquisition/divestiture fees and related costs, and IEEPA tariff refunds of (82).

For the nine months ended June 30, net sales were $ 13,781, earnings before income taxes were 2,492, net earnings common stockholders were $ 1,947, and diluted earnings per common share were $ 3.46. Adjusted EBITA was $ 3,647 at 26.5 % of sales, while adjusted earnings per share were $ 4.72. The filing does not print a fiscal 2025 nine-month comparison, so no year-over-year assessment of the nine-month period can be made from this document.

Capital allocation, liquidity and cash generation cannot be assessed from this filing because it contains no cash flow, cash, debt, dividend or repurchase disclosures. Similarly, the absence of segment and operating indicators means the reported sales and earnings changes cannot be attributed to demand, price, volume, mix or geography from the supplied document.

Not in the filing

stated, not guessed
  • Gross profit and gross margin
  • Operating income and operating margin
  • Fiscal 2025 nine months ended June 30 comparative results
  • Segment revenue and segment profitability
  • Orders, backlog, volume, pricing, organic growth and geographic metrics
  • Forward revenue, margin, expense, tax-rate or earnings guidance
  • Prior guidance for comparison
  • Operating cash flow and free cash flow
  • Cash, debt and other balance-sheet figures
  • Share repurchases and dividends
  • Named executive commentary and CFO commentary

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Third quarter 2026

AlphAI · Earnings readEMR · Third quarter 2026 · ended June 30, 2026

Emerson Reports Third Quarter 2026 Results; Raises 2026 Outlook

✓Strong quarter

Third-quarter net sales increased 7%, underlying orders increased 7%, adjusted segment EBITA margin expanded 140 bps to 28.5%, adjusted EPS increased 13%, and free cash flow increased 36%. Management raised its fiscal 2026 outlook.

Revenue
$4.87B
7% y/y
Control Systems & Software
$1.20B
7% y/y
EPS · non-GAAP
$1.71
13% y/y
2026 Q4 and 2026 outlook
Net Sales Growth: ~5% (2026 Q4); ~5% (2026)

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Underlying Ordersother7%–7%
Net SalesGAAP$4.87B–7%
Underlying Salesother6%–6%
Cost of salesGAAP$2.22B––
SG&A expensesGAAP$1.34B––
Other deductions, netGAAP$311M––
Interest expense, netGAAP$85M––
Earnings from continuing operations before income taxesGAAP$916M––
Pretax Earnings MarginGAAP18.8%–270 bps
Income taxesGAAP$198M––
Earnings from continuing operationsGAAP$718M––
Net earningsGAAP$718M––
Net earnings common stockholdersGAAP$718M––
Diluted average shares outstandingGAAP561.1M––
GAAP Earnings Per Share, continuing operationsGAAP$1.28–24%
Diluted earnings per common shareGAAP$1.28––
Adjusted Segment EBITAnon-GAAP$1.39B––
Adjusted Segment EBITA Marginnon-GAAP28.5%–140 bps
Adjusted Earnings Per Sharenon-GAAP$1.71–13%
Operating Cash FlowGAAP$1.43B–34%
Free Cash Flownon-GAAP$1.32B–36%
Nine Months Net SalesGAAP$13.78B––
Nine Months Earnings from continuing operations before income taxesGAAP$2.48B––
Nine Months Earnings from continuing operationsGAAP$1.94B––
Nine Months Net earningsGAAP$1.94B––
Nine Months Net earnings common stockholdersGAAP$1.94B––
Nine Months Diluted earnings per common shareGAAP$3.45––
Nine Months Adjusted Segment EBITAother$13.78B–5%

Segments

SegmentRevenueq/qy/y
Control Systems & SoftwareUnderlying sales growth was 7%.$1.20B–7%
Test & MeasurementUnderlying sales growth was 23%.$445M–23%
Software & SystemsUnderlying sales growth was 11%.$1.64B–11%
SensorsUnderlying sales growth was 7%.$1.09B–8%
Final ControlUnderlying sales growth was 3%.$1.59B–4%
Intelligent DevicesUnderlying sales growth was 5%.$2.68B–6%
Safety & ProductivityUnderlying sales growth was 2%.$552M–3%

2026 Q4 and 2026 outlook

  • RevenueNet Sales Growth: ~5% (2026 Q4); ~5% (2026)
  • NoteUnderlying Sales Growth: ~5% (2026 Q4); ~3.5% (2026)
  • NoteEarnings Per Share: ~$1.45 (2026 Q4); ~$4.89 (2026)
  • NoteAmortization of intangibles: ~$0.34 (2026 Q4); ~$1.39 (2026)
  • NoteRestructuring and related costs: ~$0.03 (2026 Q4); ~$0.24 (2026)
  • NoteAcquisition/divestiture fees and related costs: ~$0.01 (2026 Q4); ~$0.09 (2026)
  • NoteDiscrete taxes: ~$0.02 (2026 Q4); ~$0.05 (2026)
  • NoteIEEPA tariff refunds: - (2026 Q4); ~($0.11) (2026)
  • NoteAdjusted Earnings Per Share: ~$1.85 (2026 Q4); ~$6.55 (2026)
  • NoteOperating Cash Flow: ~$4.1B (2026)
  • NoteFree Cash Flow: ~$3.6B (2026)

Capital returns

  • Quarterly cash dividend of $0.555 per share of common stock payable September 10, 2026 to stockholders of record on August 14, 2026.
  • The 2026 outlook assumes returning ~$2.2B through ~$1B share repurchases and ~$1.2B of dividends.
  • Nine months ended June 30, 2026 dividends paid were $935 million.
  • Nine months ended June 30, 2026 purchases of common stock were $898 million.

What drove it

  • Underlying orders increased 7%, led by Software & Systems and broad-based growth in North America and Asia.
  • Software & Systems sales increased 11%, including 23% growth in Test & Measurement.
  • Intelligent Devices sales increased 6%, with Sensors up 8%, Final Control up 4%, and Safety & Productivity up 3%.
  • Third-quarter sales growth by geography was 8% in the Americas and 8% in Asia, Middle East & Africa.

Concerns

  • Third-quarter sales growth in Europe was (1)%.
  • The conflict in the Middle East remains fluid.
  • The company identified economic and currency conditions, market demand, pricing, cybersecurity, tariffs, competitive and technological factors, and inflation among risks and uncertainties.
  • The 2026 outlook includes ~($0.11) of IEEPA tariff refunds.

What to watch

  • Whether the 2026 Q4 outlook of ~5% net sales growth and ~5% underlying sales growth is delivered.
  • Whether adjusted earnings per share reaches ~$1.85 in 2026 Q4 and ~$6.55 in 2026.
  • Whether fiscal 2026 operating cash flow and free cash flow reach ~$4.1B and ~$3.6B, respectively.
  • Demand trends in Software & Systems, North America and Asia, and whether Europe returns to growth.
  • Execution of the outlook assumption to return ~$2.2B through ~$1B share repurchases and ~$1.2B of dividends.

Balance sheet and cash flow

  • Cash and equivalents were $2,180 million at June 30, 2026, compared with $1,544 million at September 30, 2025.
  • Short-term borrowings and current maturities of long-term debt were $5,587 million at June 30, 2026, compared with $4,797 million at September 30, 2025.
  • Long-term debt was $7,526 million at June 30, 2026, compared with $8,319 million at September 30, 2025.
  • Total assets were $42,208 million at June 30, 2026, compared with $41,964 million at September 30, 2025.
  • Nine months ended June 30, 2026 cash provided by operating activities was $2,902 million, compared with $2,088 million.
  • Nine months ended June 30, 2026 capital expenditures were $284 million, compared with $263 million.
  • Nine months ended June 30, 2026 cash used in investing activities was $322 million, compared with $393 million.
  • Nine months ended June 30, 2026 cash used in financing activities was $1,920 million, compared with $3,019 million.
  • Ending cash and equivalents were $2,180 million, compared with $2,219 million.

Analysis

Emerson reported a strong third quarter ended June 30, 2026. Net sales were $4,873 million, up 7%, while underlying sales increased 6% and underlying orders increased 7%. Management identified Software & Systems and broad-based growth in North America and Asia as demand drivers. Sales growth was strongest in Test & Measurement at 23% and Software & Systems at 11%, while Europe sales growth was (1)%.

Profitability improved materially. Pretax earnings were $916 million and pretax earnings margin was 18.8%, compared with $734 million and 16.1%. Adjusted segment EBITA increased to $1,387 million from $1,232 million, and adjusted segment EBITA margin expanded to 28.5% from 27.1%. GAAP earnings per share from continuing operations were $1.28, while adjusted earnings per share were $1.71.

Cash generation also improved in the quarter, with operating cash flow of $1,425 million and free cash flow of $1,323 million. For the nine months ended June 30, 2026, cash provided by operating activities was $2,902 million and capital expenditures were $284 million. Cash and equivalents were $2,180 million at June 30, 2026. The company expects to pivot capital allocation toward shareholder returns, with its fiscal 2026 outlook assuming ~$2.2B returned through ~$1B of share repurchases and ~$1.2B of dividends.

Management raised fiscal 2026 guidance. The company expects ~5% net sales growth and ~3.5% underlying sales growth for 2026, adjusted earnings per share of ~$6.55, operating cash flow of ~$4.1B, and free cash flow of ~$3.6B. For 2026 Q4, the outlook calls for ~5% net sales growth, ~5% underlying sales growth, earnings per share of ~$1.45, and adjusted earnings per share of ~$1.85.

The principal reported areas requiring attention are Europe, where third-quarter sales declined (1)%, the fluid Middle East conflict, and the impact of tariffs. The full-year outlook includes ~($0.11) of IEEPA tariff refunds. Delivery against the Q4 growth, EPS, cash-flow, and capital-return framework will determine whether the third-quarter operating momentum is sustained through fiscal year-end.

Management, verbatim

Emerson had an outstanding third quarter with sales, margin expansion, earnings and cash flow all exceeding expectations.

Lal Karsanbhai, President and Chief Executive Officer

Demand was robust, with underlying orders up 7%, led by Software & Systems and broad-based growth in North America and Asia.

Lal Karsanbhai, President and Chief Executive Officer

We are raising our full year guidance, reflecting our strong third quarter performance and healthy demand.

Lal Karsanbhai, President and Chief Executive Officer

Not in the filing

stated, not guessed
  • Prior-quarter comparisons for reported quarterly metrics.
  • Gross profit and gross margin.
  • GAAP operating income and operating margin.
  • Non-GAAP net income.
  • Quarterly capital expenditures.
  • A separate quarterly balance-sheet debt total.
  • Guidance for gross margin, operating expenses, and tax rate.
  • Previous-release outlook for comparison with actual results.
  • Complete continuation of the segment earnings table beyond the truncated filing text.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about EMR earnings dates

When is Emerson Electric's next earnings date?
AlphAI has no date for EMR yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.